DENTSPLY SIRONA (NASDAQ:XRAY) Downgraded by StockNews.com to “Hold”

Posted by Defense World Staff on Jun 17th, 2023

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

Several other equities analysts have also issued reports on the company. TheStreet raised DENTSPLY SIRONA from a “d+” rating to a “c” rating in a report on Tuesday, February 28th. The Goldman Sachs Group raised their price objective on shares of DENTSPLY SIRONA from $34.00 to $39.00 and gave the company a “neutral” rating in a research report on Wednesday, March 1st. Barrington Research lifted their price target on shares of DENTSPLY SIRONA from $43.00 to $51.00 in a research report on Thursday, May 4th. Morgan Stanley lifted their price target on shares of DENTSPLY SIRONA from $39.00 to $45.00 and gave the company an “overweight” rating in a research report on Wednesday, April 19th. Finally, Stifel Nicolaus raised their price objective on shares of DENTSPLY SIRONA from $37.00 to $41.00 in a research note on Thursday, May 4th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $42.13.

DENTSPLY SIRONA Trading Up 3.5 %

XRAY opened at $39.73 on Friday. DENTSPLY SIRONA has a one year low of $26.48 and a one year high of $43.24. The stock has a market capitalization of $8.44 billion, a PE ratio of 14.25, a P/E/G ratio of 2.18 and a beta of 0.93. The business’s 50 day moving average price is $39.83 and its 200 day moving average price is $36.90. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.93 and a current ratio of 1.41.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last posted its quarterly earnings data on Wednesday, May 3rd. The medical instruments supplier reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.05. DENTSPLY SIRONA had a positive return on equity of 8.65% and a negative net margin of 26.41%. The business had revenue of $978.00 million for the quarter, compared to analyst estimates of $938.16 million. During the same quarter in the prior year, the company earned $0.52 earnings per share. The company’s revenue was up .9% on a year-over-year basis. As a group, equities research analysts expect that DENTSPLY SIRONA will post 1.91 EPS for the current year.

Insiders Place Their Bets

In related news, Director Eric Brandt sold 6,200 shares of the business’s stock in a transaction dated Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total transaction of $261,454.00. Following the completion of the sale, the director now owns 44,902 shares of the company’s stock, valued at approximately $1,893,517.34. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.74% of the stock is currently owned by company insiders.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently made changes to their positions in XRAY. Ontario Teachers Pension Plan Board raised its holdings in shares of DENTSPLY SIRONA by 23.3% during the first quarter. Ontario Teachers Pension Plan Board now owns 8,795 shares of the medical instruments supplier’s stock valued at $345,000 after acquiring an additional 1,663 shares during the period. ProShare Advisors LLC increased its stake in DENTSPLY SIRONA by 14.0% in the 1st quarter. ProShare Advisors LLC now owns 33,162 shares of the medical instruments supplier’s stock valued at $1,303,000 after buying an additional 4,072 shares during the period. JPMorgan Chase & Co. increased its stake in DENTSPLY SIRONA by 12.3% in the 1st quarter. JPMorgan Chase & Co. now owns 469,556 shares of the medical instruments supplier’s stock valued at $18,444,000 after buying an additional 51,311 shares during the period. Manitou Investment Management Ltd. acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth $89,000. Finally, Chevy Chase Trust Holdings LLC increased its stake in shares of DENTSPLY SIRONA by 1.0% during the 1st quarter. Chevy Chase Trust Holdings LLC now owns 126,490 shares of the medical instruments supplier’s stock worth $4,969,000 after purchasing an additional 1,281 shares during the last quarter. 98.52% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.